No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
CABA241220P7500
- 5.10
- +0.60+13.33%
15min DelayClose Dec 20 16:00 ET
5.10High5.10Low
5.10Open4.50Pre Close2 Volume11 Open Interest7.50Strike Price1.02KTurnover0.00%IV-0.84%PremiumDec 20, 2024Expiry Date5.12Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.47Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Wells Fargo Downgrades Cabaletta Bio(CABA.US) to Hold Rating, Cuts Target Price to $6
Evercore Initiates Cabaletta Bio(CABA.US) With Hold Rating, Announces Target Price $6
Analysts Conflicted on These Healthcare Names: Verastem (VSTM), Roche Holding AG (OtherRHHVF) and Cabaletta Bio (CABA)
BofA Securities Cuts Price Target on Cabaletta Bio to $29 From $31, Keeps Neutral Rating
Cabaletta Bio Cut to In-Line From Outperform by Evercore ISI Group
Evercore ISI Group Downgrades Cabaletta Bio to In-Line, Lowers Price Target to $6